Bearish
SMI closes at 14,279.38, down 0.81% amid global market volatility.
The Swiss Market Index (SMI) declined by 0.81% to close at 14,279.38, influenced by global market volatility and sector-specific challenges. Notably, Novartis AG's stock fell 3.5% following the disclosure of Phase III trial results, impacting the healthcare sector. Additionally, Deutsche Bank downgraded Partners Group, leading to a decrease in its share price.
Key points
- Novartis AG's stock drops 3.5% after Phase III trial results.
- Deutsche Bank downgrades Partners Group, shares decline.
- SMI closes at 14,279.38, down 0.81%.
Sources
AI-generated from public news sources. Not financial advice.
